Patent Assignment
Reel/Frame 043201/0623
Change of Name
Recorded: 2017-07-14
Pages: 4
Assignor
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Executed: 2016-04-15
Assignee
APTEVO RESEARCH AND DEVELOPMENT LLC
2401 FOURTH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
TCR Complex Immunotherapeutics
Application:
15/040,744 →
Publication:
US 2017/0008960
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jul 18, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 039382/0985 →
Assignment of Assignor's Interest
Jul 14, 2017
From: ODEGARD, VALERIE; MCMAHAN, CATHERINE J.; BAUM, PETER R.; THOMPSON, PETER A.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 043006/0618 →
Merger and Change of Name
Jul 14, 2017
From: TRUBION PHARMACEUTICALS, INC.; EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 043006/0679 →
Security Interest
Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest
Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →